BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Moran BJ, Guerra GR. Randomized controlled trials in surgical resection of colorectal peritoneal metastases: Disentangling negativity in PRODIGE 7 and PROPHYLOCHIP. Colorectal Dis 2021;23:1303-5. [PMID: 33615659 DOI: 10.1111/codi.15596] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Turner KM, Morris MC, Sohal D, Sussman JJ, Wilson GC, Ahmad SA, Patel SH. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases: A Summary of Key Clinical Trials. J Clin Med 2022;11:3406. [PMID: 35743476 DOI: 10.3390/jcm11123406] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Fung X, Li I, Chandrakumaran K, Cecil T, Dayal S, Tzivanakis A, Moran B, Mohamed F. Early postoperative intraperitoneal chemotherapy (EPIC) following cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in 632 patients with pseudomyxoma peritonei of appendiceal origin: A single institution experience. European Journal of Surgical Oncology 2022. [DOI: 10.1016/j.ejso.2022.02.002] [Reference Citation Analysis]
3 Jastrzębski T, Gościński M. HIPEC in Complementary Treatment to Cytoreductive Procedures: An Unexplained Issue After the PRODIGE 7 Trial. Ann Surg Oncol 2021;28:803-5. [PMID: 34618245 DOI: 10.1245/s10434-021-10905-2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Treasure T, Macbeth F. The evidence for surgical interventions: Lung metastasectomy outcomes in the PulMiCC trial, an observational cohort study, and big data analysis. Colorectal Dis 2021;23:1932-3. [PMID: 33894024 DOI: 10.1111/codi.15686] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]